Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: Relationships between expectations and clinical and quality of life outcomes

Arthritis Care and Research

Volumn 66, Issue 12, 2014, Pages 1799-1807

  Dasgupta, Bhaskar ^a   Combe, Bernard ^b   Louw, Ingrid ^c   Wollenhaupt, Jürgen ^d   Zerbini, Cristiano A F ^e   Beaulieu, Andre ^f   Schulze Koops, Hendrik ^g   Durez, Patrick ^h   Wolff, Veró Nica ⁱ   Yao, Ruji ^j   Weng, Haoling H ^j   Govoni, Marinella ^k   Vastesaeger, Nathan ^l  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^b LAPEYRONIE HOSPITAL   (France)

^c Panorama Medi Clinic   (South Africa)

^d Epilepsy Center for Children and Adolescents   (Germany)

^e Hospital Helió Polis   (Brazil)

^f Centre de Rhumatologie   (Canada)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁱ HOSPITAL DEL SALVADOR   (Chile)

^j MERCK RESEARCH LABORATORIES   (United States)

^k Merck Sharpe and Dohme SpA   (Italy)

^l Merck Sharp and Dohme   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GOLIMUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADD ON THERAPY; ADULT; AGED; ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; QUALITY OF LIFE; REMISSION; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; TREATMENT OUTCOME; ADOLESCENT; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; DRUG COMBINATION; MIDDLE AGED; MULTICENTER STUDY; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84910622964     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22371     Document Type: Article

References (9)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
2. Smolen JS, Aletaha D. Monitoring rheumatoid arthritis [review]. Curr Opin Rheumatol 2011;23:252-8.
3. Wen H, Schumacher HR, Li X, Gu J, Ma L, Wei H, et al. Comparison of expectations of physicians and patients with rheumatoid arthritis for rheumatology clinic visits: a pilot, multicenter, international study. Int J Rheum Dis 2012;15: 380-9.
4. Cunha-Miranda L, Costa L, Ribeiro JS. NEAR study: Needs and Expectations in Rheumatoid Arthritis. Do we know our patients needs? Acta Reumatol Port 2010;35:314-23.
5. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64: 625-39.
6. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69:964-75.
7. Combe B, Dasgupta B, Louw I, Pal S, Wollenhaupt J, Zerbini CA, et al. Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GOMORE study. Ann Rheum Dis 2014;73:477-86.
8. Hasselblad V, Allen AS. Power calculations for large multi-arm placebo-controlled studies of dichotomous outcomes. Stat Med 2003;22:1943-54.
9. McInnes IB, Combe B, Burmester G. Understanding the patient perspective: results of the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) patient needs survey. Clin Exp Rheumatol 2013;31:350-7.